Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ev symbols : NVS save search
Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape
Published: 2021-04-19 (Crawled : 18:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.53%
H: 0.09%
C: -0.12%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.11%
H: 0.67%
C: 0.5%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.77%
H: 0.33%
C: -0.02%
sensor respiratory ev device
Novartis provides update on Phase III study evaluating canakinumab (ACZ885) as second or third-line treatment in combination with chemotherapy in non-small cell lung cancer
Published: 2021-03-09 (Crawled : 06:03) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.76%
C: -0.37%
treatment lung cancer therapy cancer ev
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.